⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)

Official Title: Non-Comparative, Multi-Cohort, Single Arm, Open-Label, Phase 2 Study of Nivolumab (BMS-936558) in Classical Hodgkin Lymphoma (cHL) Subjects

Study ID: NCT02181738

Conditions

Hodgkin Disease

Study Description

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of Nivolumab in previously treated (cohorts, A, B \& C) or newly diagnosed (cohort D) classical Hodgkin Lymphoma participants.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Local Institution - 0030, Los Angeles, California, United States

Local Institution - 0009, Los Angeles, California, United States

Local Institution - 0001, Atlanta, Georgia, United States

Local Institution - 0002, Boston, Massachusetts, United States

Local Institution - 0025, Boston, Massachusetts, United States

Local Institution - 0041, Boston, Massachusetts, United States

Local Institution - 0008, Detroit, Michigan, United States

Local Institution - 0003, Rochester, Minnesota, United States

Local Institution - 0047, Hackensack, New Jersey, United States

Local Institution - 0040, Basking Ridge, New York, United States

Local Institution - 0005, New York, New York, United States

Local Institution - 0006, Allentown, Pennsylvania, United States

Local Institution - 0004, Nashville, Tennessee, United States

Local Institution - 0007, Houston, Texas, United States

Local Institution - 0032, Innsbruck, , Austria

Local Institution - 0031, Wien, , Austria

Local Institution - 0014, B-leuven, , Belgium

Local Institution - 0015, Gent, , Belgium

Local Institution - 0046, Vancouver, British Columbia, Canada

Local Institution - 0042, Toronto, Ontario, Canada

Local Institution - 0044, Praha 2, , Czechia

Local Institution - 0037, Berlin, , Germany

Local Institution - 0036, Hamburg, , Germany

Local Institution - 0033, Koeln, , Germany

Local Institution - 0034, Ulm, , Germany

Local Institution - 0019, Bologna, , Italy

Local Institution - 0020, Napoli, , Italy

Local Institution - 0035, Rozzano (milano), , Italy

Local Institution - 0016, Amsterdam, , Netherlands

Local Institution - 0038, Groningen, , Netherlands

Local Institution - 0017, Utrecht, , Netherlands

Local Institution - 0022, Hospitalet Llobregat- Barcelona, , Spain

Local Institution - 0027, Majadahonda - Madrid, , Spain

Local Institution - 0023, Marbella, , Spain

Local Institution - 0043, Swansea, Carmarthenshire, United Kingdom

Local Institution - 0012, Withington, Manchester, United Kingdom

Local Institution - 0026, Oxford, Oxfordshire, United Kingdom

Local Institution - 0013, Sutton, , United Kingdom

Contact Details

Name: Bristol-Myers Squibb

Affiliation: Bristol-Myers Squibb

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: